相关实验视频

Updated: Sep 16, 2025

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

PFKFB在癌症治疗策略中的潜在应用

Ranqi Zhang¹, Qian Zhang¹, Feng Deng²

¹School of Pharmacy, Southwest Medical University, Luzhou 646000, China.

International journal of biological macromolecules

|July 10, 2025

概括

本综述强调了酸果酸酶-2/果糖-2,6-双酸酶 (PFKFB) 酶,特别是PFKFB3和PFKFB4在癌症中的作用. 这些酶的上调驱动癌症的进展,这表明PFKFB抑制剂是潜在的治疗点.

科学领域:

生物化学生化学
癌症生物学癌症生物学
代谢途径代谢途径

背景情况:

糖解路径对于快速增殖的细胞,包括癌细胞至关重要.
果酸酶-1 (PFK-1) 是糖解中的一个关键调节酶.
果糖-2,6-双酸盐 (F-2,6-BP) 调节PFK-1活动,并由双功能酶PFK-2/FBPase-2 (PFKFB) 调节.

研究的目的:

审查癌症组织中PFKFB3和PFKFB4的上调,以及它们在致癌过程中的作用.
总结目前关于PFKFB2,PFKFB3和PFKFB4在瘤进展,转移,血管新生和自的研究.
在癌症治疗中探索针对PFKFB异酶的新型治疗策略.

主要方法:

文献综述侧重于癌症中的PFKFB异酶.
在各种癌症类型中分析PFKFB表达变化.
综合研究PFKFB2,PFKFB3和PFKFB4在瘤发生中的功能作用.

主要成果:

在癌症组织中,PFKFB3和PFKFB4的表达被上调.
PFKFB2,PFKFB3和PFKFB4与瘤进展,转移,血管新生和自有关.
有证据表明,PFKFB异酶是癌症代谢的关键驱动因素.

结论:

向PFKFB异酶,特别是PFKFB3和PFKFB4,为癌症治疗提供了一个有希望的途径.
PFKFB 抑制剂在癌症治疗的联合疗法中可能是有效的.
对PFKFB功能的进一步研究可以推进糖解向癌症策略.

关键词:

癌症癌症癌症癌症葡萄糖溶解是什么? 葡萄糖溶解现在的PFKFB就是PFKFB 酸果基因酶是一种酸果基因酶.治疗策略治疗策略

更多相关视频

Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles

Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles

Published on: May 14, 2021

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

Inhibition of Cdk Activity

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...

Transducer Mechanism: Enzyme-Linked Receptors

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...